Exchange: NASDAQ·Updated 07:30 PM EDT

EYE News

News
all
press releases
EYE or CL: Which Is the Better Value Stock Right Now?
EYE vs. CL: Which Stock Is the Better Value Option?
Zacks
EYE or CL: Which Is the Better Value Stock Right Now?
EYE vs. CL: Which Stock Is the Better Value Option?
Zacks
More News
Why National Vision (EYE) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
Should Investors Add EYE Stock to Their Portfolios Now?
National Vision's premium-product demand and stronger customer mix support growth, but rising costs and vendor dependence remain key risks for investors.
Zacks
Why Is National Vision (EYE) Down 10.1% Since Last Earnings Report?
National Vision (EYE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
EYE or CL: Which Is the Better Value Stock Right Now?
EYE vs. CL: Which Stock Is the Better Value Option?
Zacks
EYEGLASS WORLD REFRESHES ITS BRAND WITH VML: DEBUTING "CHANGE YOUR GLASSES. CHANGE YOUR WORLD."
EYEGLASS WORLD REFRESHES ITS BRAND WITH VML: DEBUTING "CHANGE YOUR GLASSES. CHANGE YOUR WORLD." EYEGLASS WORLD REFRESHES ITS BRAND WITH VML: DEBUTING "CHANGE YOUR GLASSES. CHANGE YOUR WORLD." PR Newswire ALPHARETTA, Ga., Sept. 8, 2026 A nationwide brand refresh that unlocks personal...
PR Newswire
National Vision (EYE) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
Can Cost Savings Offset Inflation & Protect Clorox's Margins?
CLX is using cost savings, ERP optimization and pricing to cushion inflation, but the FY27 gross margin is still projected at 42%.
Zacks
Down 27.8% in 4 Weeks, Here's Why National Vision (EYE) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for National Vision (EYE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Zacks
Zacks.com featured highlights LifeStance Health, NVIDIA, Valero, Comfort and National Vision
LifeStance Health, NVIDIA, Valero, Comfort and National Vision have been highlighted in this Screen of The Week article.
Zacks

Advertisement|Remove ads.